Literature DB >> 18607770

In vitro interaction between the N-terminus of the Ewing's sarcoma protein and the subunit of RNA polymerase II hsRPB7.

Roumiana Todorova1.   

Abstract

In vivo and in vitro expressed N-terminal sequence of EWS (EAD) and hsRPB7 (subunit of human RNA polymerase II) were probed for protein-protein interactions using pull-down assays. In result, it was found that the proteins 57Z (residues 1-57 of EAD) and hsRPB7 interact in vitro forming a stable complex. The direct interaction between 57z and hsRPB7 indicate that DHR-related peptides and other small molecules, targeted to N-terminus of EWS might possess therapeutic potentialities as anti-cancer agents to function as inhibitors of EAD-mediated transactivation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18607770     DOI: 10.1007/s11033-008-9308-2

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  24 in total

1.  The splicing factor U1C represses EWS/FLI-mediated transactivation.

Authors:  L L Knoop; S J Baker
Journal:  J Biol Chem       Date:  2000-08-11       Impact factor: 5.157

2.  Dissociable Rpb4-Rpb7 subassembly of rna polymerase II binds to single-strand nucleic acid and mediates a post-recruitment step in transcription initiation.

Authors:  S M Orlicky; P T Tran; M H Sayre; A M Edwards
Journal:  J Biol Chem       Date:  2000-11-21       Impact factor: 5.157

3.  A repetitive element containing a critical tyrosine residue is required for transcriptional activation by the EWS/ATF1 oncogene.

Authors:  L Feng; K A Lee
Journal:  Oncogene       Date:  2001-07-12       Impact factor: 9.867

4.  Towards a proteome-scale map of the human protein-protein interaction network.

Authors:  Jean-François Rual; Kavitha Venkatesan; Tong Hao; Tomoko Hirozane-Kishikawa; Amélie Dricot; Ning Li; Gabriel F Berriz; Francis D Gibbons; Matija Dreze; Nono Ayivi-Guedehoussou; Niels Klitgord; Christophe Simon; Mike Boxem; Stuart Milstein; Jennifer Rosenberg; Debra S Goldberg; Lan V Zhang; Sharyl L Wong; Giovanni Franklin; Siming Li; Joanna S Albala; Janghoo Lim; Carlene Fraughton; Estelle Llamosas; Sebiha Cevik; Camille Bex; Philippe Lamesch; Robert S Sikorski; Jean Vandenhaute; Huda Y Zoghbi; Alex Smolyar; Stephanie Bosak; Reynaldo Sequerra; Lynn Doucette-Stamm; Michael E Cusick; David E Hill; Frederick P Roth; Marc Vidal
Journal:  Nature       Date:  2005-09-28       Impact factor: 49.962

5.  EWS, but not EWS-FLI-1, is associated with both TFIID and RNA polymerase II: interactions between two members of the TET family, EWS and hTAFII68, and subunits of TFIID and RNA polymerase II complexes.

Authors:  A Bertolotti; T Melot; J Acker; M Vigneron; O Delattre; L Tora
Journal:  Mol Cell Biol       Date:  1998-03       Impact factor: 4.272

6.  Multiple domains mediate transformation by the Ewing's sarcoma EWS/FLI-1 fusion gene.

Authors:  S L Lessnick; B S Braun; C T Denny; W A May
Journal:  Oncogene       Date:  1995-02-02       Impact factor: 9.867

7.  Transforming activity of EWS/FLI is not strictly dependent upon DNA-binding activity.

Authors:  S Jaishankar; J Zhang; M F Roussel; S J Baker
Journal:  Oncogene       Date:  1999-09-30       Impact factor: 9.867

8.  Tyrosine kinase Pyk2 mediates G-protein-coupled receptor regulation of the Ewing sarcoma RNA-binding protein EWS.

Authors:  J S Felsch; W S Lane; E G Peralta
Journal:  Curr Biol       Date:  1999-05-06       Impact factor: 10.834

9.  Interaction of the EWS NH2 terminus with BARD1 links the Ewing's sarcoma gene to a common tumor suppressor pathway.

Authors:  Laura Spahn; Robert Petermann; Christine Siligan; Johannes A Schmid; Dave N T Aryee; Heinrich Kovar
Journal:  Cancer Res       Date:  2002-08-15       Impact factor: 12.701

10.  Monoclonal antibodies specific for the carboxy terminus of simian virus 40 large T antigen.

Authors:  H MacArthur; G Walter
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

View more
  8 in total

1.  Heterotrimeric Gα subunit from wheat (Triticum aestivum), GA3, interacts with the calcium-binding protein, Clo3, and the phosphoinositide-specific phospholipase C, PI-PLC1.

Authors:  Hala Badr Khalil; Zhejun Wang; Justin A Wright; Alexandra Ralevski; Ariel O Donayo; Patrick J Gulick
Journal:  Plant Mol Biol       Date:  2011-07-03       Impact factor: 4.076

2.  RGG boxes within the TET/FET family of RNA-binding proteins are functionally distinct.

Authors:  Bess Ling Chau; King Pan Ng; Kim K C Li; Kevin A W Lee
Journal:  Transcription       Date:  2016-05-09

3.  Expression of multiple membrane-associated phospholipase A1 beta transcript variants and lysophosphatidic acid receptors in Ewing tumor cells.

Authors:  Benjamin Joachim Schmiedel; Christoph Hutter; Manuela Hesse; Martin Sebastian Staege
Journal:  Mol Biol Rep       Date:  2010-12-04       Impact factor: 2.316

4.  The RNA Pol II sub-complex hsRpb4/7 is required for viability of multiple human cell lines.

Authors:  Yang Zhao; Kim K C Li; King Pan Ng; Chi Ho Ng; Kevin A W Lee
Journal:  Protein Cell       Date:  2012-10-17       Impact factor: 14.870

5.  Factors Affecting EWS-FLI1 Activity in Ewing's Sarcoma.

Authors:  David Herrero-Martin; Argyro Fourtouna; Stephan Niedan; Lucia T Riedmann; Raphaela Schwentner; Dave N T Aryee
Journal:  Sarcoma       Date:  2011-11-10

Review 6.  Structure-function based molecular relationships in Ewing's sarcoma.

Authors:  Roumiana Todorova
Journal:  Biomed Res Int       Date:  2015-01-22       Impact factor: 3.411

7.  RNA polymerase II subunit 3 regulates vesicular, overexpressed in cancer, prosurvival protein 1 expression to promote hepatocellular carcinoma.

Authors:  Peng Hu; Binfeng Wang; Ting Chen; Yongfu Xu; Guoqun Zheng; Yu Zhu; Xuefeng Du
Journal:  J Int Med Res       Date:  2021-04       Impact factor: 1.671

8.  Comprehensive profiling of mRNA splicing indicates that GC content signals altered cassette exon inclusion in Ewing sarcoma.

Authors:  Garrett T Graham; Saravana P Selvanathan; Stefan K Zöllner; Emily Stahl; Adam Shlien; Natasha J Caplen; Aykut Üren; Jeffrey A Toretsky
Journal:  NAR Cancer       Date:  2022-01-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.